262 related articles for article (PubMed ID: 15885525)
1. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.
Xie H; McHugo GJ; Helmstetter BS; Drake RE
Schizophr Res; 2005 Jun; 75(2-3):337-48. PubMed ID: 15885525
[TBL] [Abstract][Full Text] [Related]
2. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.
Drake RE; McHugo GJ; Xie H; Fox M; Packard J; Helmstetter B
Schizophr Bull; 2006 Jul; 32(3):464-73. PubMed ID: 16525088
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
4. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.
Drake RE; Xie H; McHugo GJ; Shumway M
Biol Psychiatry; 2004 Nov; 56(10):749-56. PubMed ID: 15556119
[TBL] [Abstract][Full Text] [Related]
5. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI
Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758
[TBL] [Abstract][Full Text] [Related]
6. A 10-year study of steady employment and non-vocational outcomes among people with serious mental illness and co-occurring substance use disorders.
McHugo GJ; Drake RE; Xie H; Bond GR
Schizophr Res; 2012 Jul; 138(2-3):233-9. PubMed ID: 22546432
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.
Drake RE; Luciano AE; Mueser KT; Covell NH; Essock SM; Xie H; McHugo GJ
Schizophr Bull; 2016 Jan; 42(1):202-11. PubMed ID: 26294706
[TBL] [Abstract][Full Text] [Related]
8. Long-term course of substance use disorders among patients with severe mental illness.
Bartels SJ; Drake RE; Wallach MA
Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
10. [Dual diagnosis in psychoactive substance abusing or dependent persons].
Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
12. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.
Haywood TW; Kravitz HM; Grossman LS; Cavanaugh JL; Davis JM; Lewis DA
Am J Psychiatry; 1995 Jun; 152(6):856-61. PubMed ID: 7755114
[TBL] [Abstract][Full Text] [Related]
13. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
14. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
Margolese HC; Carlos Negrete J; Tempier R; Gill K
Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
[TBL] [Abstract][Full Text] [Related]
15. Current research on co-occurring substance-use disorder in schizophrenia.
Drake RE; Green AI
Schizophr Bull; 2006 Oct; 32(4):616-7. PubMed ID: 16896056
[No Abstract] [Full Text] [Related]
16. State psychiatric hospital patients with past arrests for violent crimes.
Grossman LS; Haywood TW; Cavanaugh JL; Davis JM; Lewis DA
Psychiatr Serv; 1995 Aug; 46(8):790-5. PubMed ID: 7583479
[TBL] [Abstract][Full Text] [Related]
17. Treatment of co-occurring psychotic and substance use disorders.
Mueser KT; Gingerich S
Soc Work Public Health; 2013; 28(3-4):424-39. PubMed ID: 23731429
[TBL] [Abstract][Full Text] [Related]
18. Music therapy: a novel motivational approach for dually diagnosed patients.
Ross S; Cidambi I; Dermatis H; Weinstein J; Ziedonis D; Roth S; Galanter M
J Addict Dis; 2008; 27(1):41-53. PubMed ID: 18551887
[TBL] [Abstract][Full Text] [Related]
19. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
20. [Psychotic disorders and drug abuse in adolescents].
Fleischhaker C; Priemer K; Schulz E; Remschmidt H
Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):87-95. PubMed ID: 12053878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
